| pubmed-article:6607213 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6607213 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
| pubmed-article:6607213 | lifeskim:mentions | umls-concept:C0024264 | lld:lifeskim |
| pubmed-article:6607213 | lifeskim:mentions | umls-concept:C0312740 | lld:lifeskim |
| pubmed-article:6607213 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
| pubmed-article:6607213 | lifeskim:mentions | umls-concept:C0205359 | lld:lifeskim |
| pubmed-article:6607213 | lifeskim:mentions | umls-concept:C1709059 | lld:lifeskim |
| pubmed-article:6607213 | lifeskim:mentions | umls-concept:C1511636 | lld:lifeskim |
| pubmed-article:6607213 | lifeskim:mentions | umls-concept:C0205296 | lld:lifeskim |
| pubmed-article:6607213 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
| pubmed-article:6607213 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:6607213 | pubmed:dateCreated | 1984-3-19 | lld:pubmed |
| pubmed-article:6607213 | pubmed:abstractText | Cytotoxic effector cell populations in murine spleen can be characterized by the phenotype of the cytotoxic cells or the nature of target cells. Lytic events can be antigen-specific, MHC-restricted and clonal, or target cell-specific but apparently non-MHC-restricted. Two cytotoxic effectors of this latter category are spontaneous and natural killers. Normal spleen cells from (BALB/c X DBA/2J)F1 mice (CDF1) cultured without added antigen develop a population of Thy-1+ spontaneous cytotoxic lymphocytes (SCTL) that lyse the DBA/2J mastocytoma P815, as well as the BALB/c-derived plasmacytomas MOPC-11 and SP2/0. Cold target competition experiments reveal the BALB/c-derived plasmacytomas MOPC-11, SP2/0, J558 and the A strain-derived T cell lymphoma YAC-1, but not normal lymphoblasts, block the lysis of P815 target cells. Thus, while these tumour cells appear to express common antigens which are recognized by SCTL cells, plasmacytomas such as J558 are not susceptible to lysis by SCTL. The relationship of SCTL to natural killer (NK) cells was examined. In-vivo treatment of mice with monoclonal anti-Thy-1 antibody leads to a rapid loss of SCTL and precursors from the spleen, but there is a concomitant increase in NK cell activity. | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6607213 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6607213 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6607213 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6607213 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:6607213 | pubmed:issn | 0019-2805 | lld:pubmed |
| pubmed-article:6607213 | pubmed:author | pubmed-author:WatsonJ DJD | lld:pubmed |
| pubmed-article:6607213 | pubmed:author | pubmed-author:BidawidSS | lld:pubmed |
| pubmed-article:6607213 | pubmed:author | pubmed-author:Le GrosG SGS | lld:pubmed |
| pubmed-article:6607213 | pubmed:author | pubmed-author:HerbertA GAG | lld:pubmed |
| pubmed-article:6607213 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6607213 | pubmed:volume | 51 | lld:pubmed |
| pubmed-article:6607213 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6607213 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6607213 | pubmed:pagination | 377-85 | lld:pubmed |
| pubmed-article:6607213 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:6607213 | pubmed:meshHeading | pubmed-meshheading:6607213-... | lld:pubmed |
| pubmed-article:6607213 | pubmed:meshHeading | pubmed-meshheading:6607213-... | lld:pubmed |
| pubmed-article:6607213 | pubmed:meshHeading | pubmed-meshheading:6607213-... | lld:pubmed |
| pubmed-article:6607213 | pubmed:meshHeading | pubmed-meshheading:6607213-... | lld:pubmed |
| pubmed-article:6607213 | pubmed:meshHeading | pubmed-meshheading:6607213-... | lld:pubmed |
| pubmed-article:6607213 | pubmed:meshHeading | pubmed-meshheading:6607213-... | lld:pubmed |
| pubmed-article:6607213 | pubmed:meshHeading | pubmed-meshheading:6607213-... | lld:pubmed |
| pubmed-article:6607213 | pubmed:meshHeading | pubmed-meshheading:6607213-... | lld:pubmed |
| pubmed-article:6607213 | pubmed:meshHeading | pubmed-meshheading:6607213-... | lld:pubmed |
| pubmed-article:6607213 | pubmed:meshHeading | pubmed-meshheading:6607213-... | lld:pubmed |
| pubmed-article:6607213 | pubmed:meshHeading | pubmed-meshheading:6607213-... | lld:pubmed |
| pubmed-article:6607213 | pubmed:meshHeading | pubmed-meshheading:6607213-... | lld:pubmed |
| pubmed-article:6607213 | pubmed:meshHeading | pubmed-meshheading:6607213-... | lld:pubmed |
| pubmed-article:6607213 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6607213 | pubmed:articleTitle | In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. III. Spontaneous and natural cytotoxic effector cells. | lld:pubmed |
| pubmed-article:6607213 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6607213 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6607213 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6607213 | lld:pubmed |
